Investor Relations
Mar 23, 2018
OPKO Health Enrolls First Patient in Phase 2b Study of OPK88003 to Treat Type 2 Diabetes MORE >>
Mar 16, 2018
OPKO Health Announces Landmark Study Showing 4Kscore® Test is Strong Predictor of Prostate Cancer Mortality Published in European Urology MORE >>
Mar 01, 2018
OPKO Health Reports 2017 Fourth Quarter Business Highlights and Financial Results MORE >>
Feb 26, 2018
OPKO Health to Announce Fourth Quarter and Year End 2017 Financial Results on March 1, 2018 MORE >>

SEC Filings

Form Description Filing date View
D View HTML
D View HTML
15-12G

15-12G    

View HTML
424B7

424B7    

View HTML
424B7

424B7    

View HTML
PRE 14C

A preliminary proxy statement containing all other information

View HTML
PRE 14C

A preliminary proxy statement containing all other information

View HTML
PRE 14C

A preliminary proxy statement containing all other information

View HTML
PRE 14C

A preliminary proxy statement containing all other information

View HTML
PRE 14A

A preliminary proxy statement providing notification matters to be brought to a vote

View HTML